Outrage as ovarian cancer patients are denied revolutionary drug
26 May 2015
Commenting on the decision not to prescribe olaparib on the
NHS, Professor Jonathan Ledermann (UCL CRUK Cancer Trials Centre) described the
verdict as 'devastating'. Read: Daily Mail